Cargando…
Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts
This study evaluated the efficacy of donor recipient chimeric cell (DRCC) therapy created by fusion of donor and recipient derived bone marrow cells (BMC) in chimerism and tolerance induction in a rat vascularized composite allograft (VCA) model. Twenty-four VCA (groin flaps) from MHC-mismatched ACI...
Autores principales: | Cwykiel, Joanna, Jundzill, Arkadiusz, Klimczak, Aleksandra, Madajka-Niemeyer, Maria, Siemionow, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110509/ https://www.ncbi.nlm.nih.gov/pubmed/33970329 http://dx.doi.org/10.1007/s00005-021-00614-9 |
Ejemplares similares
-
The Positive Impact of Donor Bone Marrow Cells Transplantation into Immunoprivileged Compartments on the Survival of Vascularized Skin Allografts
por: Jundziłł, Arkadiusz, et al.
Publicado: (2021) -
Chimerism-Based Experimental Models for Tolerance Induction in Vascularized Composite Allografts: Cleveland Clinic Research Experience
por: Siemionow, Maria, et al.
Publicado: (2013) -
Human Multi-Chimeric Cell (HMCC) Therapy as a Novel Approach for Tolerance Induction in Transplantation
por: Siemionow, Maria, et al.
Publicado: (2023) -
Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy
por: Siemionow, Maria, et al.
Publicado: (2018) -
Novel Human Umbilical Di-Chimeric (HUDC) cell therapy for transplantation without life-long immunosuppression
por: Siemionow, Maria, et al.
Publicado: (2023)